Items Tagged ‘copanlisib’

October 18th, 2017

FDA Approves Aliqopa for Treatment of Adults with Relapsed Follicular Lymphoma

By

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients with relapsed follicular lymphoma, the cancer often comes back even after multiple treatments,” said Richard Pazdur, M.D., director of […]

View full entry

Tags: Aliqopa, copanlisib, Follicular Lymphoma, News, Non-Hodgkin's Lymphoma